Table 1 Univariable analysis for risk factors of coronary artery aneurysm persistence
Variables | CAA regression (n = 76) | CAA persistence (n = 29) | Sig. |
|---|---|---|---|
Gender | Â | Â | 0.633 |
 Female | 23 (30.27%) | 7 (24.14%) |  |
 Male | 53 (69.73%) | 22 (75.86%) |  |
 Complications in CNS | 21 (27.63%) | 7 (24.14%) | 0.808 |
 Incomplete KD | 40 (52.63%) | 16 (55.17%) | 0.831 |
 IVIG resistance | 19 (25.00%) | 9 (31.03%) | 0.623 |
 Relapsed KD | 29 (38.16%) | 8 (27.58%) | 0.366 |
 White blood cell (×109/L) | 14.25 ± 5.07 | 14.07 ± 5.98 | 0.882 |
 Neutrophils (%) | 64.31 ± 13.96 | 74.42 ± 11.01 | 0.001* |
 Lymphocyte (%) | 25.37 ± 11.92 | 18.32 ± 8.71 | 0.004* |
 Ratio of neutrophils to lymphocyte | 3.65 ± 3.76 | 5.73 ± 4.19 | 0.016* |
 Monocyte (%) | 10.31 ± 4.08 | 7.25 ± 3.97 | 0.001* |
 Hemoglobin (g/L) | 107.61 ± 12.06 | 111.17 ± 10.85 | 0.167 |
 Platelet (×109/L) | 352.14 ± 150.97 | 394.34 ± 166.93 | 0.216 |
 Ratio of platelet to lymphocyte | 125.33 ± 82.08 | 186.91 ± 129.49 | 0.005* |
 CRP (mg/L) | 87.35 ± 55.21 | 78.68 ± 48.41 | 0.459 |
 ESR (mm/h) | 59.97 ± 28.62 | 70.84 ± 32.34 | 0.115 |
 Alanine aminotransferase (ALT, U/I) | 57.92 ± 65.26 | 71.31 ± 117.60 | 0.461 |
 Aspartate aminotransferase (AST, U/I) | 50.29 ± 59.88 | 104.03 ± 130.87 | 0.005* |
 Ratio of AST to ALT | 1.28 ± 0.77 | 2.41 ± 1.82 | 0.000* |
 Total Bilirubin (umol/L) | 9.37 ± 10.06 | 8.53 ± 14.14 | 0.741 |
 Direct bilirubin (DBIL, umol/L) | 5.94 ± 8.24 | 4.74 ± 12.30 | 0.598 |
 Indirect bilirubin (umol/L) | 4.21 ± 3.47 | 3.87 ± 3.64 | 0.682 |
 Albumin (ALB, g/L) | 35.72 ± 6.52 | 36.99 ± 5.94 | 0.366 |
 Prealbumin (PA, g/L) | 62.83 ± 31.37 | 72.69 ± 46.85 | 0.422 |
 γ-Glutamyl transpeptidase (γ-GT, U/L) | 88.26 ± 92.75 | 41.76 ± 31.24 | 0.009* |
 Lactate dehydrogenase (LDH, U/L) | 383.79 ± 193.87 | 394.17 ± 202.01 | 0.812 |
 Urea nitrogen (UN, mmol/L) | 3.26 ± 1.86 | 3.45 ± 3.11 | 0.723 |
 Creatinine (Cr, umol/L) | 28.48 ± 11.55 | 31.17 ± 14.99 | 0.344 |
 Serum cystain C (CysC, umol/L) | 1.01 ± 0.38 | 0.94 ± 0.52 | 0.667 |
  K+ (mmol/L) | 4.26 ± 0.58 | 4.18 ± 0.68 | 0.568 |
 Na+ (mmol/L) | 134.86 ± 15.03 | 137.31 ± 4.73 | 0.393 |
 P- (mmol/L) | 1.33 ± 0.28 | 1.41 ± 0.27 | 0.201 |
 Cl- (mmol/L) | 102.39 ± 3.83 | 102.22 ± 3.84 | 0.844 |
 Ca2+ (mmol/L) | 2.28 ± 0.15 | 2.28 ± 0.18 | 0.826 |
 Mg2+ (mmol/L) | 0.93 ± 0.14 | 0.92 ± 0.09 | 0.709 |
 Total cholesterol (TC, mmol/L) | 3.04 ± 0.82 | 3.40 ± 0.69 | 0.184 |
 Triglyceride (TG, mmol/L) | 1.38 ± 0.50 | 1.72 ± 1.46 | 0.277 |
 HDL-C (mmol/L) | 0.51 ± 0.18 | 0.63 ± 0.29 | 0.072 |
 LDL-C (mmol/L) | 2.23 ± 0.81 | 2.24 ± 0.87 | 0.982 |
 PT (s) | 14.06 ± 2.71 | 13.15 ± 1.18 | 0.140 |
 APTT (s) | 36.60 ± 8.87 | 35.57 ± 6.68 | 0.638 |
 Fibrinogen (Fg, mg/dL) | 531.19 ± 147.43 | 556.95 ± 133.44 | 0.497 |
 D-dimer (mg/L) | 2.01 ± 1.44 | 1.86 ± 1.76 | 0.789 |
 CTnI (ug/L) | 0.02 ± 0.04 | 0.02 ± 0.02 | 0.740 |
 NT-BNP (pg/ml) | 2384.06 ± 4601.73 | 2279.28 ± 5989.78 | 0.941 |
 Cardiac enlargement | 13 (17.11%) | 3 (10.34%) | 0.547 |
 Valver regurgitation | 16 (21.05%) | 4 (13.79%) | 0.289 |
 Number of lesions |  |  | 0.000* |
 1 | 67 (88.16%) | 15 (51.72%) |  |
 2 | 6 (7.89%) | 8 (27.60%) |  |
 3 | 3 (3.95%) | 3 (10.34%) |  |
 4 | 0 (0%) | 3 (10.34%) |  |
 Aneurysm classification |  |  | 0.000* |
 Small | 73 (96.05%) | 12 (41.38%) |  |
 Medium | 3 (3.95%) | 13 (44.83%) |  |
 Large | 0 (0%) | 4 (13.79%) |  |
 Location of aneurysm |  |  | 0.000* |
 Left coronary artery (LCA) | 57 (75.00%) | 11 (37.93%) |  |
 Left anterior descending artery (LAD) | 5 (6.58%) | 5 (17.24%) |  |
 Left circumflex artery (LCX) | 0 (0.00%) | 0 (0.00%) |  |
 Right coronary artery (RCA) | 14 (18.42%) | 13 (44.83%) |  |
 Aneurysm size | 3.37 ± 0.34 | 5.10 ± 2.52 | 0.000* |